China Top Custom Eye Health Vitamins Factories & Suppliers

Leading the Future of Vision Care through AI-Driven Manufacturing and Pharmaceutical Excellence.

Global Insight 2024

The Global Boom of the Eye Health Vitamins Industry

The global eye health vitamins market has witnessed unprecedented growth over the last decade. As the "digital screen era" dominates our daily lives, from remote work to digital entertainment, the prevalence of Digital Eye Strain (DES) and Age-Related Macular Degeneration (AMD) has surged globally. This shift has transformed eye health from an aging-related concern into a daily wellness necessity for Gen Z, Millennials, and seniors alike.

📊

Industrial Scale & Trends

Recent market reports suggest the ocular health supplement market is projected to reach USD 3.5 billion by 2030, with a CAGR concentrated in Lutein, Zeaxanthin, and Omega-3 formulations. Manufacturers are now pivoting towards "Smart Supplementation"—integrating AI to analyze nutritional deficiencies and providing personalized eye vitamin protocols.

Why Choose QLU Health

Global Procurement Demands & China’s Manufacturing Prowess

International buyers from North America, Europe, and Southeast Asia are increasingly seeking Custom Eye Health Vitamin Factories that offer more than just bulk production. They require high-purity APIs, GMP-certified facilities, and the flexibility to create white-label (OEM/ODM) solutions that meet strict local health regulations.

🛡️

Our Core Advantages as a Leading Chinese Factory

Xian QLU Health Pharmaceutical Technology Co., Ltd. stands at the intersection of traditional pharmaceutical expertise and modern biotechnology. With bases in Shandong, Zhejiang, and Hebei, we provide:

  • Full Traceability: From raw API synthesis to finished eye care supplements.
  • Certifications: GMP, ISO, FAMI-QS, KOSHER, and HALAL compliance for global export.
  • Capacity: Massive production scales for vitamins and chemical intermediates to ensure supply chain stability.
QLU Health Factory Building
Innovation & AI

Localized Solutions and AI-Integrated Eye Care

Localization is key in the eye health sector. In the Western market, "Blue Light Protection" is the primary marketing driver, whereas in Asia, there is a significant demand for "Herbal & Botanical Eye Solutions," utilizing extracts like Chrysanthemum and Bilberry. Our R&D department utilizes AI algorithms to optimize ingredient interaction, ensuring maximum bioavailability of vitamins when processed into tinctures, capsules, or topical oils.

👁️

Scientific Formulation for Modern Needs

By leveraging pharmaceutical-grade engineering, we assist our partners in launching products that address specific localized issues, such as extreme dryness in arid climates or increased cataract risks in high-UV regions.

Corporate Profile

Xian QLU Health Pharmaceutical Technology Co., Ltd.

Xian QLU Health Pharmaceutical Technology Co., Ltd. is engaged in the development, production, and marketing of pharmaceutical products, food ingredients, vitamins, intermediates, and chemicals. QLU is headquartered in Xian, China, with 3 production bases in Shandong, Zhejiang, and Hebei separately, which have many years of experience in the production of APIs, vitamins, and chemical products.

These facilities have been certified GMP, ISO, FAMI-QS, KOSHER, HALAL, etc. we have complete control over our product development, design, and manufacturing processes, thanks to our advanced equipment, methods, and inspection facilities.

With key competencies in pharmaceuticals and food health, Richer Pharma has established extensive business networks around the world. We have Strategic Marketing Partners respectively in Mumbai and Dubai. We are ready to provide you with our best products and services.

Office Building

Company Spirit & Evolution

In the ever-changing pharmaceutical industry, the spirit of QLU is characterized by flexibility and adaptability. We embrace emerging technologies, actively adopt new scientific advancements, and continuously evolve to meet the evolving needs of patients and healthcare providers.

Milestones:

  • 2012.2: Focused on pharm products, food ingredients, and vitamins.
  • 2015.12: Expanded into global marketing of APIs and intermediates.
  • 2023.9: Full integration of production and marketing chains.
  • 2024.4: Dedicated development of next-gen chemicals and APIs.
History and Experience